Back to search results

Community-Based Exercise and Nutrition Program for Cancer Survivors

This study is looking at a community-based exercise and nutrition program for cancer survivors. Many cancer survivors experience problems with their bones, joints, muscles, heart, lungs, and how their body uses energy after treatment. This program aims to see if supervised exercise and nutrition training can help improve your confidence in staying active and eating well. Researchers want to know if the program is practical and enjoyable for participants. They will also look at how it affects your physical abilities and overall quality of life. You can join if you are 18 or older and have completed cancer treatment, or if you are a caregiver for someone who has.

Study design
This is an interventional study planning to enroll 150 participants. It is not specified if the study is randomized or blinded.
What's involved
You would participate in a supervised exercise program twice a week for 12 weeks and nutrition education once a week for 10 weeks. You would also wear an activity tracker throughout the study.
Compensation
Not stated in the trial record.
Follow-up
After the 12-week program, participants will be followed up at 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06565260

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Recruiting
NAAges 18+InterventionalSupportive care
Roswell Park Cancer Institute
~150 participants
Updated 2026-07-29 on ClinicalTrials.gov
What's tested:Exercise InterventionMedical Device Usage and EvaluationNutritional InterventionPhysical Performance TestingQuestionnaire Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients still on study (Feasibility)
Measured over At the end of the 12 week intervention
+2 more outcomes measured

Conditions

Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT06565260

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Roswell Park Cancer Institute

    Buffalo, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Andrew D Ray · PRINCIPAL_INVESTIGATOR · Roswell Park Cancer Institute

Who to contact

Andrew D. Ray
[email protected]
716-845-2381
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years.
Have had a previous cancer diagnosis and completed all therapy OR are a caregiver for a patient who has had a previous cancer diagnosis.
Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related interventions.

Exclusion

Have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia including atrial fibrillation (AFIB), multiple myeloma, or psychiatric illness/social situations that would limit compliance with study requirements.
Have orthopedic or neuromuscular disorders or arthritis that preclude participation in exercise.
Are pregnant or nursing.
History of a stem cell transplant.
Currently on steroids.
Unwilling or unable to follow protocol requirements.
Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in the study.

What this trial measures

  • Proportion of patients still on study (Feasibility)At the end of the 12 week intervention

    Feasibility will be defined as the proportion of patients still on study at the end of the 12 weeks intervention. The feasibility rate will be estimated using a 90% credible region obtained by Jeffrey's prior method. The lower bound will define a plausible lower limit for true (unobserved) feasibility rate. Will be summarized using the appropriate descriptive statistics and graphical summaries. Continuous variables will be summarized using the mean, median, standard deviation, and percentiles. Categorical variables will be summarized using frequencies and relative frequencies.

  • Percentage of patients on study after 12 weeks who complete at least 70% of intervention activities (Acceptability)At 12 weeks

    Acceptability will be determined by measuring adherence to the intervention. The adherence rate will be considered acceptable if patients complete at least 70% of the intervention activities. Will be summarized using the appropriate descriptive statistics and graphical summaries. Continuous variables will be summarized using the mean, median, standard deviation, and percentiles. Categorical variables will be summarized using frequencies and relative frequencies.

  • Patient satisfaction (Acceptability)Baseline to 3 months post-intervention

    Patient satisfaction will be determined through surveys. Will be summarized using the appropriate descriptive statistics and graphical summaries. Continuous variables will be summarized using the mean, median, standard deviation, and percentiles. Categorical variables will be summarized using frequencies and relative frequencies.